EX-99.1 2 a16-20793_1ex99d1.htm EX-99.1

EXHIBIT 99.1

 

NEWS

 

 

 

VEECO REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS

 

Third Quarter 2016 Results Summary:

 

·                  Recognized revenue of $85.5 million

·                  GAAP net loss per share of $1.78, includes pre-tax restructuring and asset impairment charges of $57.8 million

·                  Narrowed non-GAAP net loss per share to $0.05

·                  Achieved positive non-GAAP adjusted EBITDA of $2.9 million

·                  Generated $7 million in cash from operations

 

Plainview, N.Y., November 1, 2016 — Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third fiscal quarter ended September 30, 2016. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

 

U.S. dollars in millions, except per share data

 

GAAP Results

 

Q3 ‘16

 

Q3 ‘15

 

Revenue

 

$

85.5

 

$

140.7

 

Net income (loss)

 

$

(69.6

)

$

5.3

 

Diluted earnings (loss) per share

 

$

(1.78

)

$

0.13

 

 

Non-GAAP Results

 

Q3 ‘16

 

Q3 ‘15

 

Adjusted net income (loss)

 

$

(1.8

)

$

13.6

 

Adjusted EBITDA

 

$

2.9

 

$

21.8

 

Adjusted diluted earnings (loss) per share

 

$

(0.05

)

$

0.33

 

 

“Veeco executed well in the third quarter, delivering revenue above the top end of our guidance range and generating positive adjusted EBITDA and cash flows from operations,” commented John R. Peeler, Chairman and Chief Executive Officer. “We are seeing a clear improvement in LED industry conditions and solid demand for our MOCVD products. We continue to win LED lighting and display opportunities with our TurboDisc® EPIKTM700 Metal Organic Chemical Vapor Deposition (“MOCVD”) system and expand our positions in red, orange and yellow LEDs with our TurboDisc® K475i™ Arsenic Phosphide (“As/P”) system.

 

“We remain focused on improving the Company’s through-cycle profitability. We are executing against our cost reduction initiatives, including our recently announced plans to significantly reduce investments in Atomic Layer Deposition (“ALD”) technology development. These actions are expected to lower our quarterly adjusted EBITDA breakeven level to approximately $75 million in revenue, starting in the first quarter of 2017.  Overall, I’m pleased with our ongoing execution and the positive momentum of our business looking ahead,” Mr. Peeler concluded.

 

In the third quarter, the company recorded total asset impairment and restructuring charges of $57.8 million. Of these charges, the vast majority were non-cash relating to an intangible ALD asset impairment and $1.8 million were restructuring charges requiring cash.

 

1



 

Guidance and Outlook

 

The following guidance is provided for Veeco’s fourth quarter 2016:

 

·                  Revenue is expected to be in the range of $85 million to $100 million

·                  GAAP Gross Margin is expected to be in the range of 37% to 39% and non-GAAP Gross Margin is expected to be in the range of 38% to 40%

·                  GAAP Net Income (loss) is expected to be in the range of ($13) million to ($7) million and non-GAAP Net Income (loss) is expected to be in the range of ($3) million to $3 million

·                  GAAP earnings (loss) per share is expected to be in the range of ($0.34) to ($0.19) and non-GAAP earnings (loss) per share is expected to be in the range of ($0.07) to $0.07

·                  Adjusted EBITDA is expected to be between $0 and $6 million

 

Please refer to the tables at the end of this press release for further details.

 

Conference Call Information

 

A conference call reviewing these results has been scheduled for today, November 1, 2016 starting at 5:00pm ET. To join the call, dial 1-888-430-8709 (toll free) or 1-719-325-2448 and use passcode 6493222. The call will also be webcast live on the Veeco website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET this evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

 

About Veeco

 

Veeco’s process equipment solutions enable the manufacture of LEDs, displays, power electronics, compound semiconductors, hard disk drives, semiconductors, MEMS and wireless chips. We are the leader in MOCVD, MBE, Ion Beam, Wet Etch single wafer processing and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership. For information on our company, products and worldwide service and support, please visit www.veeco.com.

 

To the extent that this news release discusses expectations or otherwise makes statements about the future, such statements are forward-looking and are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include the risks discussed in the Business Description and Management’s Discussion and Analysis sections of Veeco’s Annual Report on Form 10-K for the year ended December 31, 2015 and in our subsequent quarterly reports on Form 10-Q, current reports on Form 8-K and press releases. Veeco does not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

 

-financial tables attached-

 

Veeco Contacts:

 

 

 

Investors:

Media:

Shanye Hudson 516-677-0200 x1272

Jeffrey Pina 516-677-0200 x1222

shudson@veeco.com

jpina@veeco.com

 

2



 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2016

 

2015

 

2016

 

2015

 

Net sales

 

$

85,482

 

$

140,744

 

$

238,842

 

$

370,494

 

Cost of sales

 

52,027

 

86,494

 

141,991

 

232,038

 

Gross profit

 

33,455

 

54,250

 

96,851

 

138,456

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

Research and development

 

19,892

 

19,200

 

63,545

 

57,904

 

Selling, general, and administrative

 

18,396

 

21,905

 

58,230

 

69,153

 

Amortization of intangible assets

 

5,261

 

5,891

 

15,785

 

21,832

 

Restructuring

 

1,798

 

469

 

3,993

 

3,509

 

Asset impairment

 

56,035

 

 

69,662

 

126

 

Other, net

 

795

 

207

 

884

 

(795

)

Total operating expenses, net

 

102,177

 

47,672

 

212,099

 

151,729

 

Operating income (loss)

 

(68,722

)

6,578

 

(115,248

)

(13,273

)

Interest income, net

 

260

 

161

 

713

 

442

 

Income (loss) before income taxes

 

(68,462

)

6,739

 

(114,535

)

(12,831

)

Income tax expense

 

1,136

 

1,433

 

2,677

 

9,360

 

Net income (loss)

 

$

(69,598

)

$

5,306

 

$

(117,212

)

$

(22,191

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(1.78

)

$

0.13

 

$

(2.99

)

$

(0.56

)

Diluted

 

$

(1.78

)

$

0.13

 

$

(2.99

)

$

(0.56

)

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

39,131

 

40,846

 

39,193

 

39,729

 

Diluted

 

39,131

 

40,979

 

39,193

 

39,729

 

 

3



 

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

 

September 30, 2016

 

December 31, 2015

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

274,018

 

$

269,232

 

Short-term investments

 

62,835

 

116,050

 

Accounts receivable, net

 

50,463

 

49,524

 

Inventories

 

86,651

 

77,469

 

Deferred cost of sales

 

3,165

 

2,100

 

Prepaid expenses and other current assets

 

19,099

 

22,760

 

Assets held for sale

 

12,129

 

5,000

 

Total current assets

 

508,360

 

542,135

 

Property, plant and equipment, net

 

57,557

 

79,590

 

Intangible assets, net

 

61,812

 

131,674

 

Goodwill

 

114,908

 

114,908

 

Deferred income taxes

 

1,384

 

1,384

 

Other assets

 

21,047

 

21,098

 

Total assets

 

$

765,068

 

$

890,789

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

27,455

 

$

30,074

 

Accrued expenses and other current liabilities

 

38,421

 

49,393

 

Customer deposits and deferred revenue

 

79,699

 

76,216

 

Income taxes payable

 

1,825

 

6,208

 

Current portion of long-term debt

 

361

 

340

 

Total current liabilities

 

147,761

 

162,231

 

Deferred income taxes

 

13,146

 

11,211

 

Long-term debt

 

920

 

1,193

 

Other liabilities

 

6,503

 

1,539

 

Total liabilities

 

168,330

 

176,174

 

 

 

 

 

 

 

Total stockholders’ equity

 

596,738

 

714,615

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

765,068

 

$

890,789

 

 

4



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)

(unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months ended September 30, 2016

 

GAAP

 

Share-based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

85,482

 

 

 

 

 

 

 

$

85,482

 

Gross profit

 

33,455

 

607

 

 

 

355

 

34,417

 

Gross margin

 

39.1

%

 

 

 

 

 

 

40.3

%

Research and development

 

19,892

 

(993

)

 

 

 

 

18,899

 

Selling, general, and administrative and Other

 

19,191

 

(2,143

)

 

 

(1,368

)

15,680

 

Net income (loss)

 

(69,598

)

3,743

 

5,261

 

58,831

 

(1,763

)

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(1.78

)

 

 

 

 

 

 

$

(0.05

)

Diluted

 

(1.78

)

 

 

 

 

 

 

(0.05

)

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

39,131

 

 

 

 

 

 

 

39,131

 

Diluted

 

39,131

 

 

 

 

 

 

 

39,131

 

 

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)

(unaudited)

 

Three months ended September 30, 2016

 

 

 

Asset impairment

 

56,035

 

Restructuring

 

1,798

 

Acquisition related

 

63

 

Accelerated depreciation

 

355

 

Pension termination

 

1,305

 

Non-GAAP tax adjustment *

 

(725

)

Total Other

 

58,831

 

 


* - The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

 

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

5



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)

(unaudited)

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

Three months September 30, 2015

 

GAAP

 

Share-based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

140,744

 

 

 

 

 

 

 

$

140,744

 

Gross profit

 

54,250

 

787

 

 

 

 

 

55,037

 

Gross margin

 

38.5

%

 

 

 

 

 

 

39.1

%

Research and development

 

19,200

 

(1,044

)

 

 

 

 

18,156

 

Selling, general, and administrative and Other

 

22,112

 

(3,288

)

 

 

(188

)

18,636

 

Net income (loss)

 

5,306

 

5,119

 

5,891

 

(2,675

)

13,641

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.13

 

 

 

 

 

 

 

$

0.33

 

Diluted

 

0.13

 

 

 

 

 

 

 

0.33

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

40,846

 

 

 

 

 

 

 

40,846

 

Diluted

 

40,979

 

 

 

 

 

 

 

40,979

 

 

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)

(unaudited)

 

Three months September 30, 2015

 

 

 

Restructuring

 

469

 

Acquisition related

 

188

 

One-time legal settlement

 

395

 

Non-GAAP tax adjustment *

 

(3,727

)

Total Other

 

(2,675

)

 


* - The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

 

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

6



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA

(in thousands)

(unaudited)

 

 

 

Three months ended September 30,

 

 

 

2016

 

2015

 

GAAP Net income (loss)

 

$

(69,598

)

$

5,306

 

Share-based compensation

 

3,743

 

5,119

 

Amortization

 

5,261

 

5,891

 

Asset impairment

 

56,035

 

 

Restructuring

 

1,798

 

469

 

Acquisition related

 

63

 

188

 

One-time legal settlement

 

 

395

 

Accelerated depreciation

 

355

 

 

Pension termination

 

1,305

 

 

Interest income

 

(260

)

(161

)

Depreciation

 

3,104

 

3,151

 

Income tax expense (benefit)

 

1,136

 

1,433

 

Adjusted EBITDA

 

$

2,942

 

$

21,791

 

 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

7



 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in millions, except per share amounts)

(unaudited)

 

 

 

 

 

 

 

Non-GAAP Adjustments

 

 

 

 

 

Guidance for the three months ended December 31, 2016

 

GAAP

 

Share-based
Compensation

 

Amortization

 

Other

 

Non-GAAP

 

Net sales

 

$

85 

-

$

100 

 

 

 

 

 

 

 

$

85 

-

$

100 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

31 

-

39 

 

1

 

 

 

32 

-

40 

 

Gross margin

 

37%

-

39%

 

 

 

 

 

 

 

38%

-

40%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(13)

-

$

(7)

 

5

 

4

 

1

 

$

(3)

-

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per diluted common share

 

$

(0.34)

-

$

(0.19)

 

 

 

 

 

 

 

$

(0.07)

-

$

0.07 

 

Weighted average number of shares

 

39 

 

39 

 

 

 

 

 

 

 

39 

 

40 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Adjusted EBITDA

(in millions)

(unaudited)

 

Guidance for the three months ended December 31, 2016

 

 

 

 

 

GAAP Net income (loss)

 

 

 

 

 

 

 

$

(13)

-

$

(7)

 

Share-based compensation

 

 

 

 

 

 

 

5

-

5

 

Amortization

 

 

 

 

 

 

 

4

-

4

 

Restructuring

 

 

 

 

 

 

 

1

-

1

 

Interest (income) expense

 

 

 

 

 

 

 

0

-

0

 

Depreciation

 

 

 

 

 

 

 

3

-

3

 

Income tax expense (benefit) *

 

 

 

 

 

 

 

0

-

0

 

Adjusted EBITDA

 

 

 

 

 

 

 

$

0

-

$

6

 

 


Note: Amounts may not calculate precisely due to rounding.

 

* - The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

 

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and incremental transaction-related compensation.

 

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including adjusted EBITDA, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

8